We are sorry but this premium report expired!

This market research, not available anymore on the publisher's website, was withdrawn from our database.

To get an alternative report, you can either :

  • Have a look at the list of documents hereafter
  • Launch a new search below

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

DOWNLOAD THESE REPORTS NOW!

Cholestyramine Canada and USA Report

Cholestyramine Canada and USA Report

  • $ 2 969
  • Industry report
  • by PureData
  • March 2015
  • 1990 pages

CHOLESTYRAMINE CANADA & USA REPORT The Cholestyramine Canada and USA Report gives Market Consumption / Products / Services for Canada and the USA by 6 to 10-Digit NAICS Product Codes by 3 Time series: From 1997- 2015 and Forecasts 2016- 2023 & 2023-2028. Countries covered: Canada and the USA. 59 MARKET ...

Industries: Drug and Medication | Countries: Canada, United States

Cholestyramine Eurasia Report

Cholestyramine Eurasia Report

  • $ 2 969
  • Industry report
  • by PureData
  • March 2015
  • 1964 pages

CHOLESTYRAMINE EURASIA REPORT The Cholestyramine Eurasia Report gives Market Consumption / Products / Services for 4 countries by 6 to 10-Digit NAICS Product Codes by 3 Time series: From 1997- 2015 and Forecasts 2016- 2023 & 2023-2028. Countries covered include: Kazakhstan, Kyrgyzstan, Russia, Uzbekistan ...

Industries: Drug and Medication | Countries: United States

Anti-Infective Drug News 23 FEBRUARY 2015

Anti-Infective Drug News 23 FEBRUARY 2015

  • $ 1 114
  • Industry report
  • by Espicom Business Intelligence
  • February 2015
  • 16 pages

Industry Trend Analysis - HIV Market Set To Expand Gradually; Gilead To Uphold Leadership Despite ViiV Industry Brief - Affinivax/PATH Collaborate To Advance Vaccine Candidate For Pneumococcus Industry Brief - Valneva Completes Acquisition Of Dukoral Vaccine From Crucell Industry Brief - NICE Sets Out ...

Industries: Drug and Medication | Countries: United States, Canada, Japan, India

Cancer Drug News 16 FEBRUARY 2015

Cancer Drug News 16 FEBRUARY 2015

  • $ 1 114
  • Industry report
  • by Espicom Business Intelligence
  • February 2015
  • 16 pages

Industry Trend Analysis - Novartis Under Pressure To Maximise Revenue Growth Of GSK's Oncology Portfolio Industry Brief - Kinex Licenses BCRP-Targeted Patents From Hong Kong Polytechnic University/McGill University Industry Brief - Lion Obtains Licence From NIH To Develop TIL Therapy In MM Industry Trend ...

Industries: Drug and Medication | Countries: United States, Brazil, Japan, China, World

Moderate to Severe Pain: Novel Abuse Deterrent Formulation Technologies and Emergence of Novel Mechanisms in the Management of Pain

Moderate to Severe Pain: Novel Abuse Deterrent Formulation Technologies and Emergence of Novel Mechanisms in the Management of Pain

  • $ 3 000
  • Industry report
  • by MP Advisors
  • February 2015
  • 65 pages

Pain is the leading cause of disability in the US, affecting more than cancer, diabetes and heart disease combined. Current analgesics for persistent pain are relatively ineffective, are associated with significant adverse effects or abuse liability, and do not reduce pain in all treated individuals. ...

Industries: Drug and Medication | Countries: United States

Cancer Drug News 09 FEBRUARY 2015

Cancer Drug News 09 FEBRUARY 2015

  • $ 1 114
  • Industry report
  • by Espicom Business Intelligence
  • February 2015
  • 24 pages

Industry Trend Analysis - New Compounds Fill Pipelines As R&D Expenditure Rises Industry Trend Analysis - Pfizer's Approval In BC Set To Give Positive Stroke To Company's Declining Revenues Industry Brief - Bio-Path Initiates Phase II Study Of Liposomal Grb In AML Industry Brief - FDA Approves Imbruvica ...

Industries: Drug and Medication | Countries: Germany, United States, South America

Anti-Infective Drug News 09 FEBRUARY 2015

Anti-Infective Drug News 09 FEBRUARY 2015

  • $ 1 114
  • Industry report
  • by Espicom Business Intelligence
  • February 2015
  • 20 pages

Industry Trend Analysis - Several Stakeholders To Benefit From Gilead's Expanded Deals With Indian Generics Companies Industry Trend Analysis - Novartis Vaccine Business Picks Up Owing To Expanding Meningitis Market; Well-Timed For GSK Industry Brief - Takeda Discontinues Phase II Programme For DTaP/sIPV ...

Industries: Drug and Medication | Countries: Japan, India, United States, World

World Generic Markets 02 FEBRUARY 2015

World Generic Markets 02 FEBRUARY 2015

  • $ 1 114
  • Industry report
  • by Espicom Business Intelligence
  • February 2015
  • 24 pages

Industry Trend Analysis - AstraZeneca Will Look To Other Regions As US Generic Nexium Competition Commences Industry Trend Analysis - Supreme Court Ruling Will Boost Teva's Copaxone Revenues Industry Brief - Supernus Files Oxcarbazepine Patent Lawsuit Against TWi Industry Brief - Impax Receives US Lamotrigine ...

Industries: Drug and Medication | Countries: World, United States, Australia, India, United Kingdom

CNS Drug News 02 FEBRUARY 2015

CNS Drug News 02 FEBRUARY 2015

  • $ 1 114
  • Industry report
  • by Espicom Business Intelligence
  • February 2015
  • 20 pages

Industry Trend Analysis - Branded Antidepressants Market Has High Potential Despite Current Contraction Industry Brief - AgeneBio Receives Grant For New Approach To Delaying Onset Of Alzheimer's Dementia Industry Trend Analysis - Supreme Court Ruling Will Boost Teva's Copaxone Revenues Industry Brief ...

Industries: Drug and Medication | Countries: United States, Russian Federation, World, South America, Europe

Cancer Drug News 02 FEBRUARY 2015

Cancer Drug News 02 FEBRUARY 2015

  • $ 1 114
  • Industry report
  • by Espicom Business Intelligence
  • February 2015
  • 20 pages

Industry Trend Analysis - OncoMed's Latest ODD Highlights Anti-CSC Potential Industry Brief - DSMB Recommends Continuation of Masitinib Phase II Study In Relapsed BC Industry Trend Analysis - Amgen's Filings For Kyprolis In MM Will Not Affect Celgene's Product Sales Industry Brief - MacroGenics/Janssen ...

Industries: Drug and Medication | Countries: United States, Japan

24/7 Customer Service

You can call our customer service 24 hours a day / 7 days a week

  • +1 718 618 4302

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.